Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PRICE T ROWE GROUP INCTROW · Entity 3212 | Director | March 30, 2022 | March 31, 2022 |
| Synchrony FinancialSYF · Entity 3184 | Director | May 12, 2022 | May 16, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PRICE T ROWE GROUP INC
Report date March 30, 2022 · Filed March 31, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,790.3976 |
Reported balance
After 2022-03-30 transaction · row 1
1 source rowRow 1 · 2022-03-30 · Grant · Acquired 104.9156 · Balance 22,790.3976 F1: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. |
Filing footnotes · ownership attribution and instrument terms
F1: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests.
Synchrony Financial
Report date May 12, 2022 · Filed May 16, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent UnitSEC Table I · non-derivative | Direct | 31,402 |
Reported balance
After 2022-05-12 transaction · row 1
1 source rowRow 1 · 2022-05-12 · Grant · Acquired 24 · Balance 31,402 F1: Represents dividend equivalent units accrued on May 12, 2022 as dividends that were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividend equivalent units accrued on May 12, 2022 as dividends that were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AETNA INC /PA/
Report date November 28, 2018 · Filed November 28, 2018
Section 16 reporting ended · disclosed 2018-11-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2018-11-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-11-26 · Gift · Disposed 120 · Balance 1,300 Row 2 · 2018-11-28 · Disposition to issuer · Disposed 1,300 · Balance 0 F1: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-11-28 · Disposition to issuer · Disposed 990 · Balance 0 F2: Previously reported Restricted Stock Units granted under the Non-Employee Director Compensation Plan (the "Plan") on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. |
| Deferred Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-11-28 · Disposition to issuer · Disposed 2,772.0058 · Balance 0 F3: Deferred Restricted Stock Units accrued under the Plan pursuant to the deferral of Restricted Stock Unit grants. These Deferred Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Deferred Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock.
F2: Previously reported Restricted Stock Units granted under the Non-Employee Director Compensation Plan (the "Plan") on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.
F3: Deferred Restricted Stock Units accrued under the Plan pursuant to the deferral of Restricted Stock Unit grants. These Deferred Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Deferred Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 12, 2022 Filed May 16, 2022 16:12 UTC | Synchrony Financial SYF · Entity 3184 | GrantDividend Equivalent Unit | 24 | $33.03 | $792.72 |
DisclosureSEC source: 0001601712-22-000166 · wf-form4_165273195283169.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,402 F1 · shares: Represents dividend equivalent units accrued on May 12, 2022 as dividends that were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · price: Represents dividend equivalent units accrued on May 12, 2022 as dividends that were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 16:24 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 1,186 | $34.81 | $41,284.66 |
DisclosureSEC source: 0001601712-22-000100 · wf-form4_164910384240415.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,378 F1 · date: Represents restricted stock units that will vest in full on March 31, 2023. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| March 30, 2022 Filed Mar 31, 2022 18:27 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 104.9156 | $153.10 | $16,062.58 |
DisclosureSEC source: 0001562180-22-003024 · primarydocument.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,790.3976 F1 · shares: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 16:33 UTC | Synchrony Financial SYF · Entity 3184 | GrantDividend Equivalent Unit | 17 | $43.66 | $742.22 |
DisclosureSEC source: 0001601712-22-000069 · wf-form4_164556556214763.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,192 F1 · shares: Represents dividend equivalent units accrued on February 17, 2022 as dividends that were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · price: Represents dividend equivalent units accrued on February 17, 2022 as dividends that were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 16:10 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 890 | $46.39 | $41,287.10 |
DisclosureSEC source: 0001601712-22-000012 · wf-form4_164133061540933.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,175 F1 · date: Represents restricted stock units that will vest in full on December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| December 30, 2021 Filed Jan 3, 2022 17:51 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 72.5646 | $198.14 | $14,377.95 |
DisclosureSEC source: 0001562180-22-000006 · primarydocument.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,685.482 F1 · shares: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 16:59 UTC | Synchrony Financial SYF · Entity 3184 | GrantDividend Equivalent Unit | 15 | $50.18 | $752.70 |
DisclosureSEC source: 0001601712-21-000305 · wf-form4_163709993514089.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,285 F1 · shares: Represents dividend equivalent units accrued on November 12, 2021 as dividends that were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · price: Represents dividend equivalent units accrued on November 12, 2021 as dividends that were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 16:26 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 844 | $48.88 | $41,254.72 |
DisclosureSEC source: 0001601712-21-000273 · wf-form4_163337912700342.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,270 F1 · date: Represents restricted stock units that will vest in full on September 30, 2022. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| September 29, 2021 Filed Oct 1, 2021 11:53 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 70.834 | $201.90 | $14,301.38 |
DisclosureSEC source: 0001562180-21-006173 · primarydocument.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,612.918 F1 · shares: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. Read SEC document |
| August 12, 2021 Filed Aug 16, 2021 16:59 UTC | Synchrony Financial SYF · Entity 3184 | GrantDividend Equivalent Unit | 16 | $51.62 | $825.92 |
DisclosureSEC source: 0001601712-21-000250 · wf-form4_162914752446069.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,426 F1 · shares: Represents dividend equivalent units accrued on August 12, 2021 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · price: Represents dividend equivalent units accrued on August 12, 2021 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Read SEC document |
| July 07, 2021 Filed Jul 8, 2021 18:05 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 190.07 | $204.89 | $38,943.44 |
DisclosureSEC source: 0001562180-21-004849 · primarydocument.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,542.084 F1 · shares: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to a special dividend declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 09:19 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 696 | $48.52 | $33,769.92 |
DisclosureSEC source: 0001601712-21-000220 · wf-form4_162523194246824.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,410 F1 · date: Represents restricted stock units that will vest in full on June 30, 2022. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 17:28 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 70.881 | $197.79 | $14,019.55 |
DisclosureSEC source: 0001562180-21-004577 · primarydocument.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,352.014 F1 · shares: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. Read SEC document |
| May 13, 2021 Filed May 17, 2021 16:05 UTC | Synchrony Financial SYF · Entity 3184 | GrantDividend Equivalent Unit | 23 | $45.27 | $1,041.21 |
DisclosureSEC source: 0001601712-21-000190 · wf-form4_162128187808939.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,715 F1 · shares: Represents dividend equivalent units accrued on May 13, 2021 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · price: Represents dividend equivalent units accrued on May 13, 2021 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Read SEC document |
| May 12, 2021 Filed May 14, 2021 13:35 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 1,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-003472 · primarydocument.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,281.133 F1 · shares: Pursuant to the 2017 Non-Employee Director Equity Plan, this restricted Stock Unit shares was issued at $184.56 per share, the closing price of TROW shares on May 12, 2021. The forfeiture provisions of the Stock Unit Shares and all accrued dividends attributed to such Stock Unit Shares, will vest in full and become nonforfeitable upon the earliest of the following dates: (a) the day immediately prior to the Annual Meeting that occurs in the next calendar year following the year in which the Award Shares were granted as reflected on the Notice, (b) date of death, (c) the date on which it has been determined that the award holder suffered, a Total and Permanent Disability, or (d) the date on which a Change in Control occurs, in which case the vesting will take place immediately before and contingent upon the occurrence of the Change in Control. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 16:34 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 831 | $40.66 | $33,788.46 |
DisclosureSEC source: 0001601712-21-000168 · wf-form4_161739565217816.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,692 F1 · date: Represents restricted stock units that will vest in full on March 31, 2022. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| March 30, 2021 Filed Mar 31, 2021 16:12 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 74.143 | $172.22 | $12,768.91 |
DisclosureSEC source: 0001562180-21-002487 · primarydocument.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,197.133 F1 · shares: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 16:22 UTC | Synchrony Financial SYF · Entity 3184 | GrantDividend Equivalent Unit | 35 | $37.90 | $1,326.50 |
DisclosureSEC source: 0001601712-21-000093 · wf-form4_161368332206956.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,861 F1 · shares: Represents dividend equivalent units accrued on February 16, 2021 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · price: Represents dividend equivalent units accrued on February 16, 2021 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 16:53 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 973 | $34.71 | $33,772.83 |
DisclosureSEC source: 0001601712-21-000021 · wf-form4_160988358121637.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,826 F1 · date: Represents restricted stock units that will vest in full on December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| December 30, 2020 Filed Jan 4, 2021 13:39 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 70.712 | $149.58 | $10,577.10 |
DisclosureSEC source: 0001562180-21-000008 · primarydocument.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,122.99 F1 · shares: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 16:17 UTC | Synchrony Financial SYF · Entity 3184 | GrantDividend Equivalent Unit | 52 | $29.11 | $1,513.72 |
DisclosureSEC source: 0001601712-20-000293 · wf-form4_160556140967945.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,853 F1 · shares: Represents dividend equivalent units accrued on November 12, 2020 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · price: Represents dividend equivalent units accrued on November 12, 2020 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 17:54 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 1,290 | $26.17 | $33,759.30 |
DisclosureSEC source: 0001601712-20-000238 · wf-form4_160167565874371.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,801 F1 · date: Represents restricted stock units that will vest in full on September 30, 2021. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| September 29, 2020 Filed Sep 30, 2020 16:45 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 82.382 | $127.49 | $10,502.88 |
DisclosureSEC source: 0001562180-20-006143 · primarydocument.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,052.278 F1 · price: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 16:24 UTC | Synchrony Financial SYF · Entity 3184 | GrantDividend Equivalent Unit | 69 | $24.70 | $1,704.30 |
DisclosureSEC source: 0001601712-20-000220 · wf-form4_159769587585955.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,511 F1 · shares: Represents dividend equivalent units accrued on August 13, 2020 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · price: Represents dividend equivalent units accrued on August 13, 2020 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 18:31 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 84.429 | $123.50 | $10,426.98 |
DisclosureSEC source: 0001562180-20-004799 · primarydocument.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,969.896 F1 · shares: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 16:19 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 1,524 | $22.16 | $33,771.84 |
DisclosureSEC source: 0001601712-20-000188 · wf-form4_159372113641884.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,442 F1 · date: Represents restricted stock units that will vest in full on June 30, 2021. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| May 14, 2020 Filed May 18, 2020 16:07 UTC | Synchrony Financial SYF · Entity 3184 | GrantDividend Equivalent Unit | 107 | $17.07 | $1,826.49 |
DisclosureSEC source: 0001601712-20-000156 · wf-form4_158983242865027.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,918 F1 · shares: Represents dividend equivalent units accrued on May 14, 2020 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · price: Represents dividend equivalent units accrued on May 14, 2020 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Read SEC document |
| May 13, 2020 Filed May 20, 2020 20:24 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 1,853 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-003788 · primarydocument.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,885.467 F1 · shares: 1. Pursuant to the 2017 Non-Employee Director Equity Plan, this restricted Stock Unit shares were issued at $107.94 per share, the closing price of TROW shares on May 13, 2020. The forfeiture provisions of the Stock Unit Shares and all accrued dividends attributed to such Stock Unit Shares, will vest in full and become nonforfeitable upon the earliest of the following dates: (a) the day immediately prior to the Annual Meeting that occurs in the next calendar year following the year in which the Award Shares were granted as reflected on the Notice, (b) date of death, (c) the date on which it has been determined that the award holder suffered, a Total and Permanent Disability, or (d) the date on which a Change in Control occurs, in which case the vesting will take place immediately before and contingent upon the occurrence of the Change in Control. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 16:30 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 2,098 | $16.09 | $33,756.82 |
DisclosureSEC source: 0001601712-20-000117 · wf-form4_158585939613264.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,811 F1 · date: Represents restricted stock units that will vest in full on March 31, 2021. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| March 30, 2020 Filed Mar 31, 2020 19:49 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 87.829 | $98.83 | $8,680.14 |
DisclosureSEC source: 0001562180-20-002776 · primarydocument.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,032.467 F1 · shares: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 16:07 UTC | Synchrony Financial SYF · Entity 3184 | GrantDividend Equivalent Unit | 54 | $33.82 | $1,826.28 |
DisclosureSEC source: 0001601712-20-000078 · wf-form4_158206004810391.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,713 F1 · shares: Represents dividend equivalent units accrued on February 13, 2020 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · price: Represents dividend equivalent units accrued on February 13, 2020 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 17:23 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 938 | $36.01 | $33,777.38 |
DisclosureSEC source: 0001601712-20-000012 · wf-form4_157809021826147.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,659 F1 · date: Represents restricted stock units that will vest in full on December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 16:03 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 59.802 | $121.81 | $7,284.48 |
DisclosureSEC source: 0001562180-20-000006 · primarydocument.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,944.638 F1 · shares: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. Read SEC document |
| November 14, 2019 Filed Nov 18, 2019 16:29 UTC | Synchrony Financial SYF · Entity 3184 | GrantDividend Equivalent Unit | 59 | $36.73 | $2,167.07 |
DisclosureSEC source: 0001601712-19-000267 · wf-form4_157411255203346.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,721 F1 · shares: Represents dividend equivalent units accrued on November 14, 2019 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · price: Represents dividend equivalent units accrued on November 14, 2019 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 16:15 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 991 | $34.09 | $33,783.19 |
DisclosureSEC source: 0001601712-19-000232 · wf-form4_157004728004643.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,662 F1 · date: Represents restricted stock units that will vest in full on September 30, 2020. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| September 27, 2019 Filed Oct 1, 2019 19:44 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 64.017 | $113.03 | $7,235.84 |
DisclosureSEC source: 0001562180-19-004984 · primarydocument.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,884.836 F1 · shares: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 17:06 UTC | Synchrony Financial SYF · Entity 3184 | GrantDividend Equivalent Unit | 73 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001601712-19-000196 · wf-form4_156624876230283.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,671 F1 · shares: Represents dividend equivalent units accrued on August 15, 2019 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · price: Represents dividend equivalent units accrued on August 15, 2019 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 16:57 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 974 | $34.67 | $33,768.58 |
DisclosureSEC source: 0001601712-19-000175 · wf-form4_156210104890800.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,598 F1 · date: Represents restricted stock units that will vest in full on June 30, 2020. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 17:16 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 65.5 | $109.71 | $7,186.01 |
DisclosureSEC source: 0001562180-19-003743 · primarydocument.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,820.819 F1 · shares: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. Read SEC document |
| May 16, 2019 Filed May 20, 2019 16:05 UTC | Synchrony Financial SYF · Entity 3184 | GrantDividend Equivalent Unit | 72 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001601712-19-000150 · wf-form4_155838274347343.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,624 F1 · shares: Represents dividend equivalent units accrued on May 16, 2019 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · price: Represents dividend equivalent units accrued on May 16, 2019 as dividends were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Read SEC document |
| April 26, 2019 Filed Apr 30, 2019 15:21 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 1,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-002419 · primarydocument.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,755.319 F1 · shares: 1. Pursuant to the 2017 Non-Employee Director Equity Plan, this restricted Stock Unit shares were issued at $108.05 per share, the closing price of TROW shares on April 26, 2019. The forfeiture provisions of the Stock Unit Shares and all accrued dividends attributed to such Stock Unit Shares, will vest in full and become nonforfeitable upon the earliest of the following dates: (a) the day immediately prior to the Annual Meeting that occurs in the next calendar year following the year in which the Award Shares were granted as reflected on the Notice, (b) date of death, (c) the date on which it has been determined that the award holder suffered, a Total and Permanent Disability, or (d) the date on which a Change in Control occurs, in which case the vesting will take place immediately before and contingent upon the occurrence of the Change in Control. Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 16:10 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 1,058 | $31.90 | $33,750.20 |
DisclosureSEC source: 0001601712-19-000100 · wf-form4_155423580423443.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,552 F1 · date: Represents restricted stock units that will vest in full on March 31, 2020. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| March 29, 2019 Filed Apr 1, 2019 18:59 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 57.289 | $100.12 | $5,735.77 |
DisclosureSEC source: 0001562180-19-002065 · primarydocument.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,904.319 F1 · shares: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 17:01 UTC | Synchrony Financial SYF · Entity 3184 | GrantDividend Equivalent Unit | 88 | $30.83 | $2,713.04 |
DisclosureSEC source: 0001601712-19-000062 · wf-form4_155061365062373.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,494 F1 · shares: Represents 7, 8, 7, 7, 7, 8, 8, 6, 7, 7, 7 and 10 dividend equivalent units accrued on February 14, 2019 as dividends were paid on the common shares underlying restricted stock units originally granted to the reporting person on March 31, 2016, June 30, 2016, September 30, 2016, December 31, 2016, March 31, 2017, June 30, 2017, September 30, 2017, December 31, 2017, March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018, respectively. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 16:20 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 1,439 | $23.46 | $33,758.94 |
DisclosureSEC source: 0001601712-19-000013 · wf-form4_154655034037766.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,406 F1 · date: Represents restricted stock units that will vest in full on December 31, 2019. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| December 28, 2018 Filed Jan 2, 2019 19:08 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 57.398 | $91.34 | $5,242.73 |
DisclosureSEC source: 0001127602-19-000137 · form4.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,847.03 F1 · shares: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:42 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerDeferred Restricted Stock Units · Derivative | 2,772.0058 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000176 · edgar.xml · derivative · entry 4 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,772.0058 shares Expires not disclosed F3 · derivative.exercise_price: Deferred Restricted Stock Units accrued under the Plan pursuant to the deferral of Restricted Stock Unit grants. These Deferred Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Deferred Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. F3 · price: Deferred Restricted Stock Units accrued under the Plan pursuant to the deferral of Restricted Stock Unit grants. These Deferred Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Deferred Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. F3 · derivative.exercise_date: Deferred Restricted Stock Units accrued under the Plan pursuant to the deferral of Restricted Stock Unit grants. These Deferred Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Deferred Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. F3 · derivative.expiration_date: Deferred Restricted Stock Units accrued under the Plan pursuant to the deferral of Restricted Stock Unit grants. These Deferred Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Deferred Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:42 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerRestricted Stock Units · Derivative | 990 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000176 · edgar.xml · derivative · entry 3 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 990 shares Expires not disclosed F2 · derivative.exercise_price: Previously reported Restricted Stock Units granted under the Non-Employee Director Compensation Plan (the "Plan") on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. F2 · price: Previously reported Restricted Stock Units granted under the Non-Employee Director Compensation Plan (the "Plan") on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. F2 · derivative.exercise_date: Previously reported Restricted Stock Units granted under the Non-Employee Director Compensation Plan (the "Plan") on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. F2 · derivative.expiration_date: Previously reported Restricted Stock Units granted under the Non-Employee Director Compensation Plan (the "Plan") on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:42 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerCommon Stock | 1,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000176 · edgar.xml · nonDerivative · entry 2 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. Read SEC document |
| November 26, 2018 Filed Nov 28, 2018 16:42 UTC | AETNA INC /PA/ AET · Entity 107289 | GiftCommon Stock | 120 | $0.00 | $0.00 |
DisclosureSEC source: 0001122304-18-000176 · edgar.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.